In other studies, PMN-MDSCs are recruited by MCP-1 or G-CSF derived from hypoxic tumor cells to pre-metastatic lungs, where they may inhibit the cytotoxicity of NK cells (195, 196). This evidence concerns the gene CCL2 and neoplasm.